Prescription medicine

Tilmanocept Brand names: Kit

Tilmanocept (Kit) is a prescription medicine. No generic is listed in FDA's NDC Directory.

No generic listed

Check it at the source: the tilmanocept FDA label on DailyMed (effective August 28, 2026); every tilmanocept label on DailyMed.

Highlights of the record

FDA label of August 28, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026

Used for

From the label: indications and usage
Lymphoseek is a radioactive diagnostic agent indicated with or without scintigraphic imaging for:
Lymphatic mapping using a handheld gamma counter to locate lymph nodes draining a primary tumor site in adult and pediatric patients age one month and older with solid tumors for which this procedure is a component of intraoperative management.

Forms and strengths

Kit.

On the market

Generic approvals: No generic approved
Labelers listed (NDC): 1 of which 0 under generic applications, 1 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC): Not in the survey
Shortage (FDA): No current entry
Recalls by its makers (FDA): No recall recorded

What is tilmanocept used for?

From the label: indications and usage
Lymphoseek is a radioactive diagnostic agent indicated with or without scintigraphic imaging for:
Lymphatic mapping using a handheld gamma counter to locate lymph nodes draining a primary tumor site in adult and pediatric patients age one month and older with solid tumors for which this procedure is a component of intraoperative management.
Guiding sentinel lymph node biopsy using a handheld gamma counter in patients with clinically node negative squamous cell carcinoma of the oral cavity, breast cancer or melanoma. […]

Source: FDA drug label (Kit for the preparation of Lymphoseek (technetium Tc 99m tilmanocept)), Cardinal Health 414, LLC, effective August 28, 2026 (SPL set 72f31b09-4d7b-475c-b37a-9daf2ad80240), via openFDA; the full label on DailyMed

Is there a generic for tilmanocept (Kit)?

No generic tilmanocept is approved (Drugs@FDA, October 8, 2026).

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What does the tilmanocept label say about other medicines?

The tilmanocept label names 1 other medicine in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine named	Section	What the label says
Iron dextran	warnings and precautions	Serious hypersensitivity reactions have been associated with dextran and modified forms of dextran (such as iron dextran drugs).

Check tilmanocept against other medicines

What next?

Check an interaction: what two or more labels say about each other